-
News | 2020.09.03
Monkeypox: the epidemic potential will continue increasing, with diminishing herd immunity against viruses responsible for smallpox
Monkeypox is an emerging infectious disease for which outbreak frequency and expected outbreak size in human populations have steadily increased. The geographic spread of monkeypox cases has expanded beyond the forests of central Africa, where cases were initially found, to other parts of the world, where cases have been imported. This transmission pattern is likely due to the worldwide decline...
-
Document de presse | 2021.01.19
COVID-19: a lentiviral vaccine candidate for intranasal administration provides sterilizing protection in animal models
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical models, of a COVID-19 vaccine candidate using a lentiviral vector administered by nasal route. Their study demonstrates that the vaccine candidate induces antibody response with strong neutralizing activity against SARS-CoV-2, as well as...
-
Page avancée | 2020.09.15
Startup creation
Startup creation plays a major role in the downstream development of technologies stemming from academic research. With the creation of its first spin-off twenty years ago, the Institut Pasteur was a forerunner in supporting the creation and development of biotech companies.To date, the Institut Pasteur has participated in the creation and/or development of 30 startups harnessing technologies and...
-
Document de presse | 2020.09.10
Editorial: How can we reach a level of herd immunity that will protect us from COVID-19?
Epidemiological theory teaches us that a microbial agent introduced into a population stops circulating when the proportion of the population that is immune to that agent is higher than or equal to 1-1/R0, where R0 is the much-discussed reproduction rate, the number of secondary cases generated by each infected person in a non-immune population in the absence of control measures. In France, where...
-
CNR/CCOMS | 2020.09.17
CRBIP DOCUMENTS
Download the CRBIP LeaftetDownload the CRBIP Quality Manual
-
News | 2020.07.27
"Mental anchorpoints" used by musicians to identify pitch
How do we recognize pitch? An observational study carried out by the Institut Pasteur with the support of the French Society of Authors, Composers and Publishers of Music (SACEM), involving interviews with nearly 70 musicians (music students and professionals), addressed this question and found some initial answers. Musicians recognize pitch by drawing on three mental sensory modalities (auditory...
-
Fiche maladie | 2020.09.23
Meningococcal meningitis
Meningitis is an infection of the spinal cord and the brain membranes – or meninges –, caused by several types of virus, bacteria and fungi. Meningococci (another name for Neisseria meningitidis bacteria) are the main cause of acute meningitis. Despite treatment, meningococcal infections have a high mortality rate (10%) and considerable epidemic potential.
-
Document de presse | 2020.09.21
Cocaine addiction : impact of genetic mutations elucidated
Cocaine addiction is a chronic disorder with a high rate of relapse for which no effective treatment is currently available. Scientists from the Institut Pasteur, the CNRS, Inserm and the Paris Public Hospital Network (AP-HP) recently demonstrated that two gene mutations involved in the conformation of nicotinic receptors in the brain appear to play a role in various aspects of cocaine addiction...
-
News | 2020.09.23
Meningococcus and COVID-19: fewer cases of meningitis but higher incidence of pneumonia observed during the lockdown in early 2020
Although the lockdown introduced in spring 2020 undoubtedly slowed down the circulation of the coronavirus, it also had an impact on other communicable diseases. Scientists from the Institut Pasteur investigated the repercussions of the lockdown period on meningococcal diseases by comparing the number of cases between January 1 and May 15, 2019 with the number of cases over the same period in...
-
Article | 2020.10.02
TECHNOLOGY TRANSFER AND INDUSTRIAL PARTNERSHIP
Isabelle Buckle,Executive VPDr. Buckle, PhD, joined the Institut Pasteur in 2014 as Executive Vice-President for Technology Transfer and Industrial Partnership. Isabelle Buckle arrived armed with almost 30 years of scientific, commercial and business skills in Biotechnology forged from previous experiences at Bruker Daltonics as Global Vice President Clinical Mass Spectrometry (CEO and...
